Triastek announces research collaboration with Lilly
Application of 3D printing technology in oral delivery of drugs
19-Jul-2022 -
Triastek, Inc. announced a collaboration with Eli Lilly and Company to leverage the advantages of 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI tract.
According to the agreement, the project will focus on the targeted release of ...
3D printing
drug release
intestines